chromium has been researched along with zotarolimus in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cha, KS; Chae, IH; Hwang, KK; Jeon, HK; Jeong, MH; Kang, SH; Kim, HS; Kim, S; Kwon, HM; Lee, SP; Lee, SY; Moon, KW; Oh, JH; Park, BE; Park, JJ; Park, KW; Park, TH; Rhew, JY; Shin, ES; Yoon, JH | 1 |
Cha, KS; Chae, IH; Hur, SH; Hwang, KK; Jeon, HK; Jeong, MH; Kang, J; Kim, CH; Kim, HS; Kim, S; Kwon, HM; Lee, BR; Lee, SY; Moon, KW; Oh, JH; Park, BE; Park, KW; Park, TH; Park, YW; Rhew, JY; Ryu, JK; Shin, ES; Yoon, JH | 1 |
2 trial(s) available for chromium and zotarolimus
Article | Year |
---|---|
The 'Harmonizing Optimal Strategy for Treatment of coronary artery stenosis - sAfety & effectiveneSS of drug-elUting stents & antiplatelet REgimen' (HOST-ASSURE) trial: study protocol for a randomized controlled trial.
Topics: Angioplasty, Balloon, Coronary; Chromium; Chromium Alloys; Coronary Stenosis; Drug Therapy, Combination; Drug-Eluting Stents; Everolimus; Humans; Platelet Aggregation Inhibitors; Platinum; Prospective Studies; Prosthesis Design; Republic of Korea; Research Design; Single-Blind Method; Sirolimus; Time Factors; Treatment Outcome | 2012 |
Long-Term Comparison of Platinum Chromium Everolimus-Eluting Stent vs. Cobalt Chromium Zotarolimus-Eluting Stent - 3-Year Outcomes From the HOST-ASSURE Randomized Clinical Trial.
Topics: Aged; Chromium; Chromium Alloys; Coronary Angiography; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platinum; Prospective Studies; Prosthesis Failure; Sirolimus | 2019 |